Unreported / Non-Citable
Background
Dehshid Nourian and Christopher Rydberg were convicted by a jury in the Northern District of Texas for their roles in a large-scale healthcare fraud scheme. The scheme recruited physicians to prescribe compound drugs to federal workers’ compensation patients covered under the Federal Employees’ Compensation Act (FECA) and Blue Cross Blue Shield (BCBS), exploiting the government’s practice of reimbursing compound drugs at rates two to three times higher than commercial payors. Nourian managed multiple participating pharmacies and recruited others to fill fraudulent prescriptions, ultimately receiving at least $20 million in profits. Rydberg handled finances for some of the pharmacies, including tax preparation and account transfers, and provided pre-filled prescription pads to participating doctors alongside Nourian.
Nourian was convicted on sixteen counts including conspiracy to commit healthcare fraud, substantive healthcare fraud, conspiracy to commit money laundering, money laundering, and conspiracy to defraud the United States. Rydberg was convicted on nine counts including conspiracy to commit healthcare fraud, conspiracy to commit money laundering, money laundering, and conspiracy to defraud the United States. Both defendants appealed, challenging the sufficiency of the evidence supporting each conviction, the propriety of the government’s closing argument, and various aspects of their sentences.
The Court’s Holding
The Fifth Circuit affirmed all convictions and sentences. On sufficiency of the evidence, the court held that FECA qualifies as a “healthcare benefit program” under 18 U.S.C. §§ 24(b), 1347, and 1349, and that ample evidence supported the jury’s findings on each count — including healthcare fraud, money laundering, and conspiracy to defraud the United States — against both defendants. The court rejected the argument that insufficient proof of knowledge undermined the money laundering convictions, finding that evidence of the defendants’ direct involvement in the underlying fraud and their movement of proceeds through multiple accounts was more than adequate.
On sentencing, the court upheld the two-level enhancement under USSG § 2B1.1(b)(2)(A)(i) for offenses involving ten or more victims, finding the district court properly relied on the Guidelines commentary definition of “victim.” The court also rejected Nourian’s challenge to the forfeiture of his entire TD Ameritrade account, holding that because he had commingled tainted fraud proceeds with other funds to conceal their source, the entire account was properly subject to forfeiture. Nourian’s challenges to the district court’s note of his lack of remorse at allocution and to the restitution order were likewise rejected — the latter being squarely foreclosed by Fifth Circuit precedent.
Key Takeaways
- FECA is a “healthcare benefit program” within the meaning of the federal healthcare fraud statute, 18 U.S.C. §§ 24(b) and 1347, and schemes targeting federal workers’ compensation are squarely within the statute’s reach.
- Commingling fraud proceeds with untainted funds to conceal their illegal origin renders an entire account subject to forfeiture — mere pooling of tainted and untainted funds alone is insufficient, but deliberate concealment is not.
- A curative jury instruction is generally sufficient to cure an improper government closing argument; defendants must show the argument actually affected their substantial rights to obtain a new trial.
- A district court’s below-Guidelines sentence is presumptively reasonable, and remarking on a defendant’s lack of remorse at allocution does not constitute reversible error where there is no indication the observation drove the § 3553(a) analysis.
Why It Matters
This decision reinforces the breadth of federal healthcare fraud liability, confirming that FECA — the workers’ compensation program for federal employees — falls within the statutory definition of a healthcare benefit program. Practitioners defending clients in compound pharmacy or workers’ compensation fraud cases should note that the court reads the statute expansively, and that conviction need not rest on defrauding a single program if multiple payors are involved.
The forfeiture ruling also carries practical significance: defendants who route fraud proceeds through layered accounts before commingling them with legitimate funds risk forfeiture of the entire commingled account, not merely the tainted portion. Combined with the court’s reaffirmation that juries are presumed to follow curative instructions, the decision illustrates the high bar defendants face in overturning jury verdicts in complex financial fraud cases on appeal.